Effects of Novel Dual GIP and GLP-1 Receptor Agonist Tirzepatide on Biomarkers of Nonalcoholic Steatohepatitis in Patients With Type 2 Diabetes
DOI: 10.2337/dc19-1892, Volume: 43, Issue: 6, Pages: 1352-1355
Article Type: brief-report,
Article History
received:
accepted:
published: